N=100
Demographic characteristics: - Age (mean, range) - Sex: male (%, frequency)	50 (19-71) 63% (63/100)
Base disease: - Lymphomas (Hodgkin and non-Hodgkin) - Multiple myeloma - Others	51% (51/100) 46% (46/100) 3% (3/100)
Response to ASCT: - Complete response - Very good partial response - Partial Response - Stable Disease - Progression disease	40.6% (39/96) 10.4% (10/96) 42.7% (41/96) 4.3% (4/96) 2% (2/96)
Pre-transplant treatment lines: - One line - Two lines - Three or more lines	29.6% (29/98) 54.1% (53/98) 16.3% (16/98)
Conditioning Regimen: - BEAM - Melphalan - Others	48.4% (46/95) 47.3% (45/95) 4.3% (4/95)
CD34+ cells infused x10e6/Kg (medium, range)	6.27 (2.2-24.6)